Clinical Trial Update: Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic Shock [Phase 3]

View source ↗

Summary

A Phase 3 trial compared meropenem alone to meropenem plus moxifloxacin for the treatment of severe sepsis and septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Meropenem (Meropenem)
• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Kompetenznetz Sepsis | Conditions: Severe Sepsis, Septic Shock | Phase 3 | Status: COMPLETED